Promisia widens first-half loss as it chases US expansion

Promisia Intergrative chief executive Charles Daily
Promisia Intergrative 12-month price history (NZX.com)

Free audio stream, including stories that are padlocked on our site. Listen on any device, anywhere. Updated twice daily. The audio stream takes several seconds to start on Android devices.

Launch Radio player

Promisia Intergrative [NZX: PIL], the listed-therapeutic health supplements company, widened its first-half loss as it looks to expand its Arthrem brand into the United States. The shares gained.

The Wellington-based company booked a loss $388,000 in the six months ended June 30, from a previous loss of $72,014 for the same period a year earlier, it said in a statement. Sales rose 85 percent to $122,000.

The company's Arthrem brand, which makes a herbal-based dietary supplement pill said to maintain long-term joint health, currently only sells in New Zealand, through distributor Pharmabroker and its online store. Chief Executive Charles Daily has relocated to the US where it wants to enter the market.

It is also spending on research to scientifically validate its herbal pills, and received funding from Callaghan Innovation, the government's innovation fund, which covered 40 percent of the cost to undertake its in vitro laboratory studies of its plant extracts which has had positive initial test results, Promisia said, without being more specific. It recieved further Callaghan assistance for its Dunedin Hospital trial.

"Our goal is to add scientific methodology and validity to an industry that is often perceived as unscientific," Promisia said in a statement. "Further development of new products, following similar steps as for Arthrem in terms of scientifically and clinically proving efficacy and safety and employing a similar sales platform, will bolster future sales growth."

Shares of Promisia rose 7.1 percent to 4.5 cents and have declined some 40 percent this year. The company also raised $567,000 from its share purchase plan and an additional placement of subscribed shares worth $1.28 million was made to a range of investors, it said. The new shares were all issued at 4.08 cents.

(BusinessDesk)


Got a question about this story? Leave it in Comments & Questions below.

This article is tagged with the following keywords. Find out more about MyNBR Tags

NZ Market Snapshot

Forex

Sym Price Change
USD 0.7313 -0.0041 -0.56%
AUD 0.9335 0.0030 0.32%
EUR 0.6599 -0.0021 -0.32%
GBP 0.4703 0.0009 0.19%
HKD 5.6697 -0.0319 -0.56%
JPY 88.9200 -0.0860 -0.10%

Commods

Commodity Price Change Time
Gold Index 1206.0 -3.510 2015-05-21T00:
Oil Brent 67.1 -0.140 2015-05-21T00:
Oil Nymex 60.7 1.730 2015-05-21T00:
Silver Index 17.1 0.019 2015-05-21T00:

Indices

Symbol Open High Last %
NZX 50 5769.3 5785.2 5769.3 0.12%
NASDAQ 5065.9 5098.2 5071.7 0.38%
DAX 11881.5 11881.8 11864.6 -0.26%
DJI 18285.9 18314.9 18285.7 0.00%
FTSE 7013.5 7061.7 7013.5 0.66%
HKSE 27723.7 28041.3 27523.7 1.70%
NI225 20208.8 20278.3 20202.9 0.30%